US Patent Issued to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGY, SHANGHAI BAOLONG PHARMACEUTICAL, BAOLONG PHARMACEUTICAL, SHANGHAI BAOLONG ANQING PHARMACEUTICAL on April 21 for "Triptolide lignocerate, liposome thereof and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,335, issued on April 21, was assigned to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGY Co. LTD. (Shanghai), SHANGHAI BAOLONG PHARMACEUTICAL Co. LTD. (Shanghai), BAOLONG PHARMACEUTICAL Co. LTD. (Anhui, China) and SHANGHAI BAOLONG ANQING PHARMACEUTICAL Co. LTD. (Anhui, China).

"Triptolide lignocerate, liposome thereof and preparation method therefor" was invented by Xin Wu (Shanghai), Hang Chen (Shanghai), Xinmei Chen (Shanghai), Jianming Chen (Shanghai), Yongjie Huang (Shanghai), Wuhao Wei (Shanghai), Xinyu Wang (Shanghai) and Mengmeng Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of...